logo

Canadian News

Share

Canadian stocks edged lower for a fourth straight session Friday, although losses were again relatively small. Despite a significant drop in the price of oil, the TSX Composite Index fell only 37 points to 16,075. Stocks have fallen since an 11-day win streak was broken Tuesday. Crude oil futures...

The Canadian stock market is down slightly in early trade Friday. Weakness in the energy sector is weighing on the market this morning, as crude oil prices have dropped back below $70 a barrel. Reports have surfaced indicating that OPEC may end its supply quota plan with Russia. After trading modestly...

The U.S. dollar advanced against its most major rivals in the early New York session on Friday, as investors took a breather from Pyongyang's measured response to the cancellation of the summit by U.S. President Trump. North Korea responded by saying they remain open to talks, with Vice Foreign Minister...

CAE Inc. (CAE.TO, CAE) reported fourth-quarter net income attributable to equity holders from continuing operations of C$100.1 million or C$0.37 per share compared to C$67.4 million or C$0.25 per share, or C$82.4 million or C$0.31 per share before specific items last year. This represents a 19% EPS increase...

Canadian stocks may fall Friday along with oil prices which tumbled below $70 a barrel. Reports surfaced indicating that OPEC may end its supply quota plan with Russia, given that production from some key members will continue to fade. Venezuela's oil industry is in tatters while Iran faces harsh...

The Canadian dollar slipped against its major counterparts in the European session on Friday, as oil prices fell following media reports that Saudi Arabia and Russia are planning to raise oil output, which would be finalized as early as June. Crude for July delivery fell $1.25 to $69.46 per barrel. OPEC...

reata-may25.jpg Reata Pharmaceuticals Inc. (RETA) has reported positive interim data from its phase II study, dubbed PHOENIX.

The euro advanced against its major counterparts in early European deals on Friday, following a data showing a better than expected German business sentiment in April. Survey data from Ifo Institute showed that the business climate index came in at 102.2 in May, unchanged from April. The score was...

Canadian stocks edged lower Thursday despite strong bank earnings. Stocks fell for a third session in arow after an 11-day win streak. The TSX Composite Index dropped 20 points to 16,113. Royal Bank of Canada (RY.TO) revealed a profit for its second quarter that increased from the same period last...

The Canadian stock market has been fluctuating between small gains and losses since the open of trade Thursday. Energy stocks are struggling this morning, due to a pullback in crude oil prices. Meanwhile, gold stocks are turning in a strong performance after the planned summit between the leaders of...

At 7.30 am ET Thursday, the European Central Bank is set to publish the minutes of April 25-26 governing council meeting. Ahead of the release, the euro eased from its early highs against its major opponents. The euro was worth 1.1716 against the greenback, 128.45 against the yen, 1.1605 against...

Royal Bank of Canada (RY, RY.TO) reported second-quarter net income of C$3.06 billion, up 9% from the prior year with double-digit EPS growth of 11% to C$2.06. The company said its results reflect strong earnings growth in Wealth Management, Personal & Commercial Banking, and Investor & Treasury Services,...

The Canadian dollar declined against its major counterparts in the Asian session on Thursday, after an official data showed an unexpected build in U.S. crude inventories last week. Crude for July delivery fell $0.26 to $71.58 per barrel. Data from the Energy Information Administration showed Wednesday...

pharma-daily-051718.jpg Today's Daily Dose brings you news about Anika's accelerated share repurchase program; Esperion's phase III study results of bempedoic acid in patients with hypercholesterolemia; TherapeuticsMD and Teva's near-term catalysts.

pharma-daily-052218.jpg Avinger Inc.'s (AVGR) next generation Pantheris Lumivascular atherectomy system with extended nosecone has been granted clearance by the FDA.

Follow RTT